Effects of an anthraquinone derivative from Rheum officinale Baill, emodin, on airway responses in a murine model of asthma

Food and Chemical Toxicology

Volumn 50, Issue 7, 2012, Pages 2368-2375

  Chu, Xiao ^a   Wei, Miaomiao ^a   Yang, Xiaofeng ^a   Cao, Qingjun ^a   Xie, Xianxing ^a   Guan, Mingfeng ^a   Wang, Dacheng ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

AMCase; Asthma; Emodin; Muc5ac; NF B; Ym2

Indexed keywords

EMODIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ACIDIC MAMMALIAN CHITINASE GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHITINASE 3 LIKE PROTEIN 4 GENE; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; EOSINOPHIL COUNT; FEMALE; GENE; GENE EXPRESSION REGULATION; GOBLET CELL; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; MUC5AC GENE; NONHUMAN; RHEUM; RHEUM OFFICINALE; SENSITIZATION; TH2 CELL; UPREGULATION;

ANIMALS; ASTHMA; BASE SEQUENCE; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; DNA PRIMERS; EMODIN; FEMALE; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; POLYMERASE CHAIN REACTION; RHEUM; TRACHEA;

MAMMALIA; MURINAE; MUS; RHEUM OFFICINALE;

EID: 84861443149     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.03.076     Document Type: Article

References (52)

1. Bao Z., et al. Glycogen synthase kinase-3b inhibition attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 2007, 176:431-438.
2. Bondeson J. The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen. Pharmacol. 1997, 29:127-150.
3. Broide D.H., et al. Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase b-dependent genes in airway epithelium. Proc. Natl. Acad. Sci. USA 2005, 102:17723-17728.
4. Chupp G.L., et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N. Engl. J. Med. 2007, 357:2016-2027.
5. Cohn L., et al. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 2004, 22:789-815.
6. Cockcroft D.W., Davis B.E. Mechanisms of airway hyperresponsiveness. J. Allergy Clin. Immunol. 2006, 118:551-559.
7. Das J., et al. A critical role for NF-κB in GATA3 expression and Th2 differentiation in allergic airway inflammation. Nat. Immunol. 2001, 2:45-50.
8. Gagliardo R., et al. Persistent activation of nuclear factor-kB signaling pathway in severe uncontrolled asthma. Am. J. Respir. Crit. Care Med. 2003, 168:1190-1198.
9. Galli S.J., et al. The development of allergic inflammation. Nature 2008, 454:445-454.
10. Galli S.J., et al. Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 2005, 23:749-786.
11. Gleich G.J. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 2000, 105:651-663.
12. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell. Signal. 2001, 13:85-94.
13. Hamelmann E., et al. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness-a murine model. Allergy 1999, 54:297-305.
14. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol. Res. 2001, 23:99-109.
15. Heo S.K., et al. Emodin inhibits TNF-alpha-induced human aortic smooth-muscle cell proliferation via caspase-and mitochondrial-dependent apoptosis. J. Cell. Biochem. 2008, 105:70-80.
16. Horie S., et al. Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern. Med. 1997, 36:179-185.
17. Holgate S., et al. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J. Allergy Clin. Immunol. 2005, 115:459-465.
18. Hogan S.P., et al. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy 2008, 38:709-750.
19. Huang H.C., et al. Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur. J. Pharmacol. 1991, 198:211-213.
20. Iwashita H., et al. Role of eosinophil chemotactic factor by T lymphocytes on airway hyperresponsiveness in a murine model of allergic asthma. Am. J. Respir. Cell. Mol. Biol. 2006, 35:103-109.
21. Jie Z., et al. The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation. Respir. Physiol. Neurobiol. 2009, 168:289-294.
22. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
23. Justice J.P., et al. CD4(1) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:1066-1074.
24. Kelly M., et al. Modulating leukocyte recruitment in inflammation. J. Allergy Clin. Immunol. 2007, 120:3-10.
25. Koyama M., et al. Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies. J. Med. Chem. 1988, 31:283-284.
26. Lee Y.S., et al. Synergistic effect of emodin in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. Pharm. Biol. 2010, 48:1285-1290.
27. Lin S.Z., et al. Emodin attenuates acute rejection of liver allografts by inhibiting hepatocellular apoptosis and modulating the Th1/Th2 balance in rats. Clin. Exp. Pharmacol. Physiol. 2010, 37:790-794.
28. Liang J.W., et al. HPLC analysis of emodin in serum, herbs and Chinese herbal prescriptions. J. Food Drug Anal. 1993, 3:251-257.
29. Lora J.M., et al. Tumor necrosis factor-a triggers mucus production in airway epithelium through an IκB kinase b-dependent mechanism. J. Biol. Chem. 2005, 280:36510-36517.
30. Lopez A.F. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988, 167:219-224.
31. Lu Y., et al. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochem. Pharmacol. 2011, 82:1700-1708.
32. Manthey C.L., et al. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leuk. Biol. 1998, 64:409-417.
33. Medoff B.D., et al. T cell trafficking in allergic asthma: the ins and outs. Annu. Rev. Immunol. 2008, 26:205-232.
34. Meng G., et al. Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-kappaB activation by disrupting lipid rafts in CD14-negative endothelial cells. Br. J. Pharmacol. 2010, 161:1628-1644.
35. Morcillo E.J., Cortijo J. Mucus and MUC in asthma. Curr. Opin. Pulm. Med. 2006, 12:1-6.
36. Pantano C., et al. Nuclear factor-κB activation in airway epithelium induces inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2008, 177:959-969.
37. Poynter M.E., et al. NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness. J. Immunol. 2004, 173:7003-7009.
38. Rogers D.F. The airway goblet cell. Int. J. Biochem. Cell. Biol. 2003, 35:1-6.
39. Sanderson C.J. Interleukin-5, eosinophils, and disease. Blood 1992, 79:3101-3109.
40. Sher A., et al. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 1990, 145:3911-3916.
41. Simon D., et al. Eosinophils and atopic dermatitis. Allergy 2004, 59:561-570.
42. Srinivas G., et al. Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent. Med. Res. Rev. 2007, 27:591-608.
43. Teran L.M., et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 1999, 20:1044-1549.
44. Towbin H., et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992, 24:145-149.
45. Tsang F., et al. Effects of mitogen-activated protein kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro. Br. J. Pharmacol. 1998, 25:61-68.
46. Umetsu D.T., DeKruyff R.H. TH1 and TH2 CD4+ cells in human allergic diseases. J. Allergy Clin. Immunol. 1997, 100:1-6.
47. Wills-Karp M., et al. Interleukin-13: central mediator of allergic asthma. Science 1998, 18:2258-2261.
48. Yang F. Preparative isolation and purification of hydroxyanthraquinones from Rheum officinale Baill by high-speed counter-current chromatography using pH-modulated stepwise elution. J. Chromatogr. A 1999, 858:103-107.
49. Zhao J., et al. Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics 2005, 5:2799-2807.
50. Zhu Z., et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004, 304:1678-1682.
51. +-ATPase of the rabbit renal medulla and their diuretic action. Acta Pharm. Sin. 1988, 23:17-20.
52. Zuhdi Alimam M. Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am. J. Respir. Cell. Mol. Biol. 2000, 22:253-260.